IMV Inc.
IMV
Clasificación en acciones
#35070
IMV Inc. is a clinical-stage biotechnology company dedicated to the development... IMV Inc. is a clinical-stage biotechnology company dedicated to the development of innovative immunotherapies. The company utilizes its proprietary DPX immune-educating technology platform to create a portfolio of treatments for various solid and hematological cancers. Its leading investigational drug, maveropepimut-S, is a DPX-based immunotherapy designed to target cancer cells that express survivin. Maveropepimut-S is currently undergoing Phase II clinical trials for diffuse large B-cell lymphoma, ovarian cancer, and specific bladder, liver, and microsatellite instability-high tumors, with Phase I trials also active for breast cancer. Beyond its primary candidate, IMV is also advancing DPX-SurMAGE, which is in Phase I clinical trials for bladder cancer, and is developing DPX-COVID-19 and DPX-RSV to address infectious diseases. Originally founded in 2000 as Immunovaccine Inc., the company adopted the name IMV Inc. in May 2018 and operates from its headquarters in Dartmouth, Canada.
Precio por acción
$0.82959892
Última sincronización: 2023-05-23
Capitalización bursátil
$4.16M
Cambio (1 día)
-0.04%
Cambio (1 año)
82,959,792.06%
País
CA
Comercio IMV Inc. (IMV)
Categoría
Healthcare
Historial del precio de la acción de IMV Inc. (IMV)
Precio más alto de cierre: $0.00 el 2024-04-01
Precio más bajo de cierre: $2.79 el 2009-10-01
Precio más bajo de cierre: $2.79 el 2009-10-01
Historial del precio de la acción de IMV Inc. desde 2009 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2024 | -99.62% |
| 2023 | -99.90% |
| 2022 | -80.41% |
| 2021 | -58.37% |
| 2020 | 14.77% |
| 2019 | -48.18% |
| 2018 | 1.97% |
| 2017 | 209.96% |
| 2016 | -4.32% |
| 2015 | -11.63% |
| 2014 | 46.23% |
| 2013 | 3.39% |
| 2012 | 10.27% |
| 2011 | -50.45% |
| 2010 | -42.36% |
| 2009 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $532.09 | 24.77% |
US
|
|
| $236.63 | 781.30% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $889.94 | 9.31% |
NL
|
|
| $291.42 | 2.39% |
BE
|
